Thursday’s Analyst Moves: Pfizer Inc., Mondelez International Inc, Tiffany & Co., More (PFE, MDLZ, TIF, More)

Before Thursday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.

UBS Downgrades Allergan

Allergan (AGN) was downgraded at AGN to “Neutral” from “Buy” at UBS, based on a valuation call and the pending offer on Valeant. UBS has a price target of $180 on AGN, suggesting an 8.5% upside to the stock’s current price. AGN has a dividend yield of 0.12%.

Barclays Downgrades Duke

Duke Energy (DUK) was downgraded from “Over Weight” to “Equal Weight” at Barclays, due to macro and operational factors. Barclays has a $77 price target on Duke, suggesting a 4% upside to the stock’s current price. DUK has a dividend yield of 4.23%.

Barclays Downgrades FedEx

Barclays downgraded FedEx (FDX) from “Over Weight” to “Equal Weight,” as Barclays believes FedEx is focused on near term growth at the expense of capital returns, and that the company is seeing stagnant profitability. Barclays has a price target of $140 on FDX, suggesting the stock will rise by 1%. FDX has a dividend yield of 0.43%.

UBS Upgrades KB Home

KB Home (